Successful treatment with vemurafenib in BRAF V600K-positive cerebral melanoma metastasis

JAMA Dermatol. 2013 May;149(5):642-4. doi: 10.1001/jamadermatol.2013.372.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / genetics
  • Brain Neoplasms / secondary
  • Female
  • Humans
  • Indoles / therapeutic use*
  • Magnetic Resonance Imaging
  • Melanoma / genetics
  • Melanoma / secondary
  • Melanoma / therapy*
  • Middle Aged
  • Proto-Oncogene Proteins B-raf / genetics*
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / surgery
  • Sulfonamides / therapeutic use*
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf